Protein Ubiquitination: In Vitro Experiments, Site Identification, and Ubiquitinated Proteomics
Protein ubiquitinationis a highly crucial post-translational modification in cellular regulation. By covalently attaching one or more ubiquitin molecules, it regulates processes such as protein degradation, subcellular localization, DNA repair, and signal transduction. In recent years, advancements in mass spectrometry and bioinformatics have expanded ubiquitination research from targeted small-scale experiments to large-scale ubiquitin proteomics. This paper focuses on three main themes: 'Protein Ubiquitination: In Vitro Assays, Site Identification, and Ubiquitin Proteomics,' detailing common experimental strategies and technical challenges from in vitro system reconstruction, lysine site identification techniques, to systematic studies of ubiquitin chain structures and proteome-level research, aiming to provide researchers with cutting-edge perspectives and practical guidance.
I. In Vitro Ubiquitination Assays
1. Immunoprecipitation and Ubiquitination Detection | IP-WB and IP-SILAC
(1) Method overview:The target protein is co-precipitated with specific antibodies or tags (such as His, FLAG) in cell lysates to detect whether it is ubiquitinated. Ubiquitin chains can be directly detected using anti-ubiquitin antibodies (such as FK2) or by using SILAC labeling combined with mass spectrometry to identify specific sites.
(2) Advantages and disadvantages:Simple and intuitive, suitable for validating candidate proteins; however, it does not provide information on the type and structure of modification chains, nor can it achieve absolute quantification.
2. In situ/in vitro recombination system | E1-E2-E3 recombination system
(1) System setup:Recombine E1 (UBA1), E2, and E3 with ubiquitin and ATP in vitro, which can reconstruct the conditions for ubiquitin to react with the target protein. In a purified system, catalytic steps can be clearly defined.
(2) Application directions:Suitable for screening potential E3 ligases, evaluating substrate specificity, and analyzing ubiquitin chain types (such as K48, K63 linkages).
(3) Challenges:Requires recombination and purification of multiple active proteins; the reaction system is complex, particularly challenging for multi-subunit E3 enzyme systems.
3. Ubiquitin Remnant Profiling
(1) Principle:After ubiquitination, rigorous enzymatic digestion (such as with trypsin) breaks down ubiquitin, leaving a 'GG' dipeptide connected to the target lysine. Enriching GG-modified peptides and conducting LC-MS/MS analysis allows for the identification of ubiquitination sites.
(2) Advantages:High sensitivity, suitable for full proteome coverage; can quantify differences in ubiquitination levels across various samples.
(3) Considerations:Optimize enrichment antibodies (anti-K-ε-GG) and strictly control background noise.
II. Site Identification
1. LC-MS/MS qualitative identification
Fragment analysis of enriched peptides through tandem mass spectrometry locates lysine ubiquitination sites based on GG residual characteristic ions. (2) In database searches (e.g., Mascot, MaxQuant), specify variable modifications as 'GG (K)'.
2. Quantitative and differential analysis
Label quantification (SILAC/iTRAQ/TMT): Quantification through isotopes or chemical tags in treatment and control groups reveals differential ubiquitination sites. (2) Label-free quantification (LFQ): Relies on intensity normalization to compare peptide abundance across samples, suitable for studies with larger sample sizes.
3. Ubiquitin chain structure and cluster modification analysis
Focuses on types of polyubiquitin chains (K48 vs K63) and their isomeric structures. (2) Techniques like side-chain retention and enzymatic digestion characteristics (e.g., DUB enzymes) combined with mass spectrometry can speculate on the topology of ubiquitin chains.
III. Ubiquitinomics Technologies
1. Multi-level enrichment strategies
Using TUBE (Tandem Ubiquitin-Binding Entities) and anti-GG dual enrichment to enhance recognition rate of ubiquitinated proteins.
2. Data processing and bioinformatics analysis
Obtain high-quality raw data through mass spectrometry platforms (e.g., Orbitrap Fusion Lumos). (2) Use specialized software (MaxQuant, Proteome Discoverer) for spectrum analysis and GG site identification. (3) Subsequent bioinformatics analysis, such as distribution of ubiquitination sites in protein functional domains, pathway enrichment (KEGG/GO), protein-protein interaction modeling (STRING) reveals ubiquitination network regulatory mechanisms.
3. Application of ubiquitinomics in new drug target discovery
By comparing samples from tumor vs normal groups, drug-treated vs control groups, changes in ubiquitination levels can identify highly differential sites as potential therapeutic targets. (2) Combined with the development of protein degradation drugs (PROTACs) or E3 inhibitors, accelerates the development of new drugs targeting ubiquitination pathways.
IV. Research Design Suggestions and Strategy Optimization
1. Experimental design and control setup
Include physiological samples and treatment groups, positive and negative controls, technical and biological replicates. (2) If studying drug effects, include dose and time gradient designs.
2. Sample processing and enzymatic digestion regulation
Fine grinding + high-efficiency inhibitor systems (such as MG132) to harvest cells/tissues can enhance ubiquitin protein volume. (2) Post-trypsin treatment with BBNJ to monitor short peptide products for GG residual site.
3. Mass spectrometry parameter presets
Adopt high-energy collision dissociation HCD mode for high-quality MS2 acquisition. (2) Recommend dynamic range MS1 broadband settings for site identification, resolution ≥120,000.
4. Data correction and validation
Preliminary results require IP-Western validation of key ubiquitinated proteins and sites. (2) Can also be complemented with E3 knockout/overexpression or CRISPR-engineered cell lines with site mutations to verify functional significance.
Protein ubiquitination research is moving towards a high-throughput, systematic new stage.Whether evaluating E3 substrate recognition in vitro or conducting full proteome quantitative studies of dynamic ubiquitination changes, mass spectrometry remains a key exploration tool. Enrichment techniques and bioinformatics analysis capabilities determine the quality and innovation of the project. Through the integration of rigorous experimental design, advanced platform capabilities, and in-depth data analysis, researchers can gain insights into cellular regulatory mechanisms, construct functional linkage networks, and ultimately apply them to the development of new drugs targeting the ubiquitin system. In this persistent integration of forces, Bio-Techne through its advanced platform, specialized technologies, and full-chain services, is becoming a reliable partner in ubiquitination research challenges. If you plan to undertake a ubiquitinomics project, please contact Bio-Techne's professional team, and we will provide comprehensive support from project design, experimental execution to result interpretation.
Bio-Techne - A premium service provider of bioproduct characterization and multi-omics mass spectrometry detection
Related services:
How to order?






